Rubella is a highly contagious disease caused by a virus, also known as German measles [1]. It is transmitted easily from person to person through respiratory secretions [1].
Aperçu de la maladie
Informations étayées par des preuves EN 5/7 sections · FR 5/7 sections Mis à jour le Oct 23, 2026
Rubella is a highly contagious viral disease that spreads readily through respiratory droplets from coughs or sneezes [1]. Global burden remains substantial, with an estimated 17,865 cases reported across 78 countries in 2022 despite an available vaccine [1]. Vaccination is the principal preventive measure, and all six WHO regions have adopted elimination goals for rubella and congenital rubella syndrome [1].
Lire le profil clinique et épidémiologique complet 6
In children the illness is usually mild, presenting with rash, low fever below 39°C, nausea, and mild conjunctivitis [1]. The rash appears in 50–80% of cases, lasts one to three days, and spreads from the face and neck downward; swollen lymph glands behind the ears and in the neck are the most characteristic sign [1]. Adults, especially women, may experience arthritis and joint pain lasting three to ten days [1].
An estimated 17,865 rubella cases occurred in 78 countries during 2022 [1]. Reported cases declined 97% from 670,894 in 102 countries in 2000 to 17,865, reflecting expanding vaccine introduction [1]. As of January 2025, 179 of 194 countries had introduced rubella-containing vaccines with global coverage near 73%, and the Americas were declared free of endemic transmission in 2015 [1].
The virus spreads easily when an infected person coughs or sneezes [1]. After infection the virus disseminates through the body over five to seven days, with symptoms appearing two to three weeks after exposure [1]. The most infectious period is typically one to five days following rash onset [1].
Vaccination is the most effective way to prevent illness and further transmission, with a safe vaccine that helps the body combat the virus [1]. The WHO recommends that countries not yet using rubella vaccine adopt it through established measles immunization programs [1]. By January 2025, 179 of 194 countries had introduced rubella-containing vaccines, supporting global elimination efforts [1].
- 1 World Health Organization. Rubella [Internet]. cited 23 Oct 2026. Available from: https://www.who.int/news-room/fact-sheets/detail/rubella
- 2 Di Pietrantonj C et al. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2021 Nov 22. PMID: 34806766. doi: 10.1002/14651858.CD004407.pub5. PubMed: https://pubmed.ncbi.nlm.nih.gov/34806766/
- 3 Gidengil C et al. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine. 2021 Jun 23. PMID: 34049735. doi: 10.1016/j.vaccine.2021.03.079. PubMed: https://pubmed.ncbi.nlm.nih.gov/34049735/
- B06
- KA63
Chargement des données actuelles…
Tendances nationales
Choisissez le pays, la source et la mesure ; chaque courbe conserve sa période et sa définition de déclaration.
Chargement des données…
Couverture des données
Pays et régions déclarants
La carte montre la couverture déclarée. Choisissez une mesure ou ouvrez un lieu coloré pour consulter ses données.
Chargement des données actuelles…
Profil de surveillance
Saisonnalité du pays sélectionné
Consultez les valeurs mensuelles d’un pays par année. Les cases vides indiquent une valeur non publiée.
Radar de recherche
Recherches récentes associées
Évalué par les pairs Accès ouvert Association forte à la maladie Rubéole
DOI 10.3390/antib15060103 ↗ Rubella Antibody Prevalence Among Women of Reproductive Age in Croatia: Implications for the Prevention of Congenital Rubella Syndrome
Antibodies
Gaps in Knowledge, Receipt, and Acceptance of Measles, Mumps, Rubella Vaccines in a National Sample of Emergency Department
UC Riverside Undergraduate Research Journal
The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000–2019
Vaccine
Trends of congenital rubella syndrome among infants (0–11 months old) in India: a multicentre hospital-based sentinel surveillance (2016–2025)
The Lancet Regional Health - Southeast Asia
Anti-Rubella antibodies seroprevalence among pregnant women in South-Western Romania
Frontiers in Medicine
5 publications associées sur 84 affichées.
Les liens bibliographiques servent à découvrir des travaux et ne modifient ni ne valident la série de surveillance ci-dessus.
Chargement des alertes officielles…
Téléchargement et méthodes
Choisissez une période et téléchargez les fichiers CSV, JSON ou XLSX.